04
May

Bayer Healthcare is stepping up with $155 million in cash and a big near-term milestone in exchange for the development and commercialization rights to an experimental anticoagulant from Isis Pharmaceuticals.

…read more

Source: Bayer fronting $155M for a promising anticoagulant from Isis Pharma

    

0 No comments